Incontinentia Pigmenti

NewsRx Bundle A quick and inexpensive way to view the most recent articles for a one-time project. Custom Reports on Incontinentia Pigmenti Tired of prepackaged reports that just don't meet your needs? Target your needs!

What is incontinentia pigmenti?

Incontinentia pigmenti is a condition affecting many body systems, particularly the skin. This disorder, which occurs mainly in females, is characterized by blistering and wart-like skin growths in early childhood followed by changes in skin pigmentation. The condition may also affect the teeth, hair, eyes, and central nervous system (the brain and spinal cord).

How common is incontinentia pigmenti?

Incontinentia pigmenti is an uncommon disorder. Between 700 and 1,000 affected individuals have been reported in the scientific literature.

What genes are related to incontinentia pigmenti?

Mutations in the IKBKG gene cause incontinentia pigmenti.

The IKBKG gene provides instructions for making a protein that helps regulate the activity of nuclear factor-kappa-B. Nuclear factor-kappa-B is a protein complex that normally helps protect cells from self-destructing (undergoing apoptosis) in response to certain signals. In about 80 percent of affected individuals, mutations in the IKBKG gene lead to an abnormally small, nonfunctional version of the IKBKG protein. Other people with incontinentia pigmenti have mutations that prevent any IKBKG protein from being produced. Without this protein, nuclear factor-kappa-B is not regulated properly, and cells are more likely to undergo apoptosis. Researchers believe that this abnormal cell death leads to the signs and symptoms of incontinentia pigmenti.

How do people inherit incontinentia pigmenti?

This condition is inherited in an X-linked dominant pattern. A condition is considered X-linked if the mutated gene that causes the disorder is located on the X chromosome, one of the two sex chromosomes. The inheritance is dominant if one copy of the altered gene in each cell is sufficient to cause the condition. In most cases, males experience more severe symptoms of the disorder than females. A striking characteristic of X-linked inheritance is that fathers cannot pass X-linked traits to their sons.

In some cases, an affected person inherits the mutation from one affected parent. Other cases may result from new mutations in the gene. These cases occur in people with no history of the disorder in their family.

Research suggests that incontinentia pigmenti occurs mainly in females because males with mutations in the IKBKG gene usually die before birth. Males with these mutations have no functional IKBKG protein in any of their cells. In females with incontinentia pigmenti, some cells produce normal protein from the IKBKG gene and other cells produce no functional IKBKG protein. The resulting overall reduction in the amount of functional IKBKG protein leads to the signs and symptoms of incontinentia pigmenti.

Source: National Institutes of Health

Reports outline central nervous system disease in children study findings from University of Alabama, College of Medicine

"Central nervous system involvement ranges from none to multiple strokes, seizures, and mental retardation. Deletions in the nuclear factor kappa beta essential modulator gene at Xq28 are present in 70-80% of patients with incontinentia pigmenti. White matter abnormalities have been reported in females with significant neurologic involvement," wrote S.A. Bryant and colleagues, University of Alabama, College of Medicine.

The researchers concluded: "This report describes a neurologically intact child with deletion positive incontinentia pigmenti with significant white matter involvement, broadening the scope of this finding in incontinentia pigmenti."

Bryant and colleagues published their study in Pediatric Neurology (Abnormal white matter in a neurologically intact child with incontinentia pigmenti. Pediatric Neurology, 2007;36(3):199-201).

For additional information, contact S.A. Bryant, University of Alabama at Birmingham College of Medicine, Birmingham, Alabama USA.

The publisher of the journal Pediatric Neurology can be contacted at: Elsevier Science Inc., 360 Park Avenue South, New York, NY 10010-1710, USA.

Keywords: United States, Birmingham, Central Nervous System Disease, Central Nervous System Injury, Incontinentia Pigmenti, Neurology, Pediatric.

This article was prepared by Pain & Central Nervous System Week editors from staff and other reports. Copyright 2007, Pain & Central Nervous System Week via NewsRx.com.